ArticleJournal of cancer research and clinical oncology2023

Analysis and prediction of the efficacy and influencing factors of camrelizumab combined with TACE and sorafenib in the treatment of advanced hepatocellular carcinoma.

Songsong Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.